Abstract
The purpose of this study was to determine the risk of adverse cardiovascular events associated with concomitant use of clopidogrel and calcium-channel blockers (CCBs) in patients with myocardial infarction (MI).
| Original language | English |
|---|---|
| Journal | Journal of the American College of Cardiology |
| Volume | 57 |
| Issue number | 4 |
| Pages (from-to) | 409-17 |
| Number of pages | 9 |
| DOIs | |
| Publication status | Published - 25 Jan 2011 |
Fingerprint
Dive into the research topics of 'Calcium-channel blockers do not alter the clinical efficacy of clopidogrel after myocardial infarction: a nationwide cohort study'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS